Leaflet: information for the user
Adolquir 25 mg powder for oral solution EFG
Dexketoprofen
Contents of the pack and additional information
This medication is a pain reliever belonging to the group of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs).
It is used in adults for the short-term symptomatic treatment of mild to moderate acute pain, such as muscle pain or joint pain, menstrual pain, and toothache pain.
Do not take Adolquir
-If you are allergic to dexketoprofen or any of the other components of this medication (listed in section 6);
-If you are allergic to acetylsalicylic acid or another nonsteroidal anti-inflammatory drug;
-If you have asthma orhhave had asthma attacks, acute allergic rhinitis (a short period of nasal mucosa inflammation), nasal polyps (fleshy formations in the nasal cavity due to allergy), urticaria (skin rash), angioedema (face, eye, lip, or tongue swelling, or difficulty breathing) or chest wheezing after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs;
-If you have had photoallergic or phototoxic reactions (a special form of skin redness or burns exposed to sunlight) during the use of ketoprofen (a nonsteroidal anti-inflammatory drug) or fibrates (medications used to reduce blood lipid levels);
-If you have chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis);
-If you have severe heart failure, moderate to severe renal insufficiency, or severe liver insufficiency;
-If you have bleeding disorders or blood clotting disorders;
-If you are severely dehydrated (have lost a lot of body fluid) due to vomiting, diarrhea, or inadequate fluid intake;
-If you are in the third trimester of pregnancy or lactation.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Adolquir:
-If you are allergic or have had allergy problems in the past;
-If you have kidney, liver, or heart diseases (hypertension and/or heart failure), or fluid retention or have had these conditions in the past;
-If you are taking diuretics or have inadequate hydration and reduced blood volume due to excessive fluid loss (for example, excessive urination, diarrhea, or vomiting);
-If you have heart problems, a history of strokes, or think you may be at risk of these conditions (for example, high blood pressure, diabetes, high cholesterol, or smoking) consult this treatment with your doctor or pharmacist. Medications like Adolquir may be associated with a small increase in the risk of heart attacks ("myocardial infarction") or strokes ("cerebrovascular accident"). Any risk is more likely to occur when high doses and prolonged treatments are used. Do not exceed the recommended dose or treatment duration;
-If you are elderly, you may be more likely to experience adverse effects (see section 4). If these occur, consult your doctor immediately;
-If you are a woman with fertility problems (see section 2, "Pregnancy, lactation, and fertility");
-If you have a disorder in blood production and blood cells;
-If you have systemic lupus erythematosus or mixed connective tissue disease (immune system diseases that affect connective tissue);
-If you have or have had chronic inflammatory bowel disease (ulcerative colitis, Crohn's disease);
-If you have or have had stomach or intestinal disorders;
-If you have an infection; see the "Infections" heading below;
-If you are taking other medications that increase the risk of peptic ulcers or bleeding, for example, oral corticosteroids, some antidepressants (SSRI type), agents that prevent blood clotting, such as acetylsalicylic acid (aspirin) or anticoagulants like warfarin or acenocoumarol (Sintrom). In these cases, consult your doctor before taking this medication: your doctor may prescribe an additional medication to protect your stomach (for example, misoprostol or other medications that block stomach acid production);
-If you have asthma, combined with rhinitis or chronic sinusitis, and/or nasal polyps, as you have a higher risk of being allergic to acetylsalicylic acid and/or NSAIDs than the general population. Administration of this medication may cause asthma attacks or bronchospasm, particularly in patients allergic to acetylsalicylic acid or NSAIDs.
Adolquir may mask the signs of an infection, such as fever and pain. Therefore, it is possible that this medication may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in pneumonia caused by bacteria and skin infections related to varicella. If you take this medication while having an infection and the infection symptoms persist or worsen, consult a doctor without delay.
Avoid using this medication if you have varicella.
Children and adolescents
This medication has not been studied in children or adolescents. Therefore, safety and efficacy have not been established and should not be used in children or adolescents.
Other medications and Adolquir
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription. There are some medications that should not be taken together and other medications that may require a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medication, you are using or being administeredany of the following medications:
Non-recommended associations:
-Acetylsalicylic acid, corticosteroids, and other anti-inflammatory drugs;
-Warfarin or acenocoumarol (Sintrom), heparin, or other medications used to prevent blood clotting;
-Lithium, used to treat mood disorders;
-Metotrexate (cancer medication and immunosuppressant), used at high doses of 15 mg/week;
-Hidantoins and phenytoin, used for epilepsy;
-Sulfamethoxazole, used for bacterial infections;
Associations requiring caution:
-Inhibitors of the ECA, diuretics, and angiotensin II antagonists, used for high blood pressure and heart conditions;
-Pentoxifylline and oxpentifylline, used to treat chronic venous ulcers;
-Zidovudine, used to treat viral infections;
- Aminoglycoside antibiotics, used for bacterial infections;
-Sulfonilureas (e.g. chlorpropamide and glibenclamide), used for diabetes;
-Metotrexate, used at low doses, less than 15 mg/week.
Associations to be considered:
-Quinolones (e.g. ciprofloxacin, levofloxacin), used for bacterial infections;
-Ciclosporin or tacrolimus, used to treat immune system diseases and organ transplants;
-Streptokinase and other thrombolytic and fibrinolytic medications; that is, medications used to dissolve blood clots;
-Probenecid, used for gout;
-Digoxin, used in the treatment of chronic heart failure;
-Mifepristone, used as an abortifacient (to interrupt pregnancy);
-SSRI-type antidepressants;
-Antiplatelet agents used to reduce platelet aggregation and blood clot formation;
-Beta-blockers, used for high blood pressure and heart conditions;
If you have any doubts about taking other medications with Adolquir, consult your doctor or pharmacist.
Adolquir with food, drinks, and alcohol
In general, it is recommended to take the medication with meals to reduce the possibility of causing stomach problems (see also section 3, "Administration form").
The use of NSAIDs in combination with alcohol may worsen the adverse reactions caused by the active ingredient.
Pregnancy, lactation, and fertility
Do not take this medication during the last three months of pregnancy or lactation.It may cause kidney and heart problems in your fetus. It may affect your predisposition and that of your baby to bleed and delay or prolong delivery more than expected.
The use of this medication may harm fertility, so it is not recommended to use it while trying to conceive or while studying a fertility problem.
Driving and using machines
This medication may slightly affect your ability to drive and use machines, as it may cause drowsiness, dizziness, and blurred vision as adverse effects of treatment. If you notice these effects, do not use machines or drive until these symptoms disappear. Consult your doctor.
Adolquir contains saccharose
If your doctor has indicated that you have an intolerance to certain sugars, consult with him before taking this medication. It contains 2,418 g of saccharose per dose, which should be taken into account in patients with diabetes mellitus.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The necessary dose of the medication may vary, depending on the type, intensity, and duration of pain. Your doctor will tell you how many packets to take per day and for how long.
The effective dose should be used for the shortest time necessary to alleviate symptoms. If you have an infection, consult a doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults 18 years and older
Generally, the recommended dose is 1 packet (25 mg of dexketoprofen) every 8 hours, not exceeding 3 packets per day (75 mg).
Patients with advanced age or renal or hepatic insufficiency
If you are an elderly patient, or suffer from mild renal problems or mild to moderate liver problems, it is recommended to start therapy with a maximum of 2 packets per day (50 mg of dexketoprofen).
In elderly patients, this initial dose can be increased later according to the general recommended dose (75 mg of dexketoprofen) if the medication has been well tolerated.
Do not use dexketoprofen if you have moderate or severe renal problems, or severe liver problems. Consult your doctor or pharmacist if you are unsure.
Use in children and adolescents
This medication should not be used in children and adolescents (under 18 years old).
Administration form
Dissolve the entire content of a packet in a glass of water; shake/stir to help dissolve. The obtained solution should be taken immediately after reconstitution.
The medication can be taken with or without food. Taking the medication with food helps to reduce the risk of gastrointestinal disturbances, however, if your pain is more intense and you need faster relief, take the packet on an empty stomach (at least 15 minutes before any meal or ingestion of food) because it will be absorbed more easily (see section 2 "Taking Enandol with food, drinks, and alcohol").
If you take more Adolquir than you should
Consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91.562.04.20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Adolquir:
Do not take a double dose to compensate for the missed doses. Take the next dose when due (according to section 3 “How to take Adolquir”).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The possible side effects are listed below in order of frequency. Since the list is based in part on the side effects observed with oral use of tablets, and since the granulated powder for oral solution is absorbed more quickly than tablets, it is possible that the actual frequency of side effects (gastrointestinal) may be higher in the granulated powder for oral solution.
Frequent side effects: may affect up to 1 in 10 people
Nausea and/or vomiting, mainly upper abdominal pain, diarrhea, digestive disorders (dyspepsia).
Less frequent side effects: may affect up to 1 in 100 people
Dizziness (vertigo), dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, stomach wall inflammation (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feverish sensation and chills, general discomfort.
Rare side effects: may affect up to 1 in 1,000 people
Peptic ulcer, perforation of peptic ulcer or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention and peripheral edema (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood analysis), liver cell damage (hepatitis), acute renal insufficiency.
Very rare: may affect up to 1 in 10,000 people
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin ulcers, mouth, eyes, and genital areas (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or lip and throat swelling (angioedema), difficulty breathing due to narrowing of airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis inflammation, blurred vision, ringing in the ears (tinnitus), sensitive skin, light sensitivity, itching, kidney problems. Decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia).
Inform your doctor immediately if you notice any gastrointestinal side effects at the start of treatment (e.g., stomach pain or burning or bleeding), if you have previously experienced any of these side effects due to prolonged treatment with anti-inflammatory drugs, and especially if you are elderly.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesions inside the mouth or on the genitals, or any other sign of allergy.
During treatment with nonsteroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Adolquir may be associated with a small increase in the risk of suffering a heart attack ("myocardial infarction") or a stroke ("cerebral infarction").
In patients with autoimmune disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory drugs may rarely cause fever, headache, and neck stiffness.
The most commonly observed side effects are of a gastrointestinal nature. They may cause peptic ulcers, perforation or bleeding, sometimes fatal, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis and Crohn's disease have been reported. Less frequently, gastric wall inflammation (gastritis) has been observed.
Like other NSAIDs, anaphylactic reactions (purpura, aplastic and hemolytic anemia, and more rarely agranulocytosis and medullary hypoplasia) may occur.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the overwrap after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Adolquir
- The active ingredient is dexketoprofen (as dexketoprofen trometamol). Each sachet contains 25 mg of dexketoprofen.
- The other components are: ammonium glycyrrhizate, neohesperidin dihydrochalcone, quinoline yellow (E-104), lemon aroma, and sucrose (see section 2, Adolquir contains sucrose).
Appearance of Adolquirand contents of the packaging
Yellow lemon-colored granule.
The oral solution granule is presented in single-dose, thermosealed, stucco-aluminum-polyethylene sachets.
It is presented in packs of 20 and 500 sachets.
Only some sizes of packs may be marketed.
Marketing authorization holder and manufacturer responsible
LABORATORIOS MENARINI, S.A.
Alfons XII, 587
08918 Badalona (Barcelona) Spain
Last review date of this leaflet:April 2023
Other sources of information
The detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.